R&D Trends

Whole genome sequencing of Alzheimer’s patients to be made available to researchers

Friday, July 12, 2013 01:28 PM

The Alzheimer's Association and the Brin Wojcicki Foundation have announced new data has been generated by the "Big Data" project for Alzheimer's disease. The data will be made freely available to researchers worldwide to advance Alzheimer's science.

More... »

Amgen, Servier announce product collaboration

Thursday, July 11, 2013 01:01 PM

Biotechnology company Amgen and privately-run French research-based pharmaceutical company Servier have entered a collaboration agreement leveraging each company's commitment to cardiovascular disease.

More... »

Forma Therapeutics, CRT collaborate

Thursday, July 11, 2013 12:11 PM

Forma Therapeutics and Cancer Research Technology (CRT), the commercialization company of Cancer Research U.K., have announced a research initiative to discover tools, technologies and therapeutic drug candidates against a variety of protein homeostasis regulators called deubiquitinating enzymes (DUBs).

More... »

Loxo Oncology, Array BioPharma in license, collaboration agreement

Thursday, July 11, 2013 09:10 AM

Loxo Oncology, a biopharmaceutical company established and funded by Aisling Capital, and Array BioPharma have announced a multi-year license and collaboration agreement for an Array-invented preclinical development candidate and related intellectual property. In addition, Loxo and Array will collaborate to discover and develop small molecule drugs for mutually agreed upon novel oncology targets. 

More... »

AstraZeneca inks cancer collaboration

Wednesday, July 10, 2013 12:27 PM

AstraZeneca has entered into an agreement with the University of Cambridge and Cancer Research U.K. for a two-year collaboration on three preclinical and clinical oncology projects. This agreement aims to advance cancer research through the study of tumor mutations and new investigational therapies in prostate, pancreatic and potentially other cancers.

More... »

Immunocore, GlaxoSmithKline sign research and licensing agreement

Wednesday, July 10, 2013 12:26 PM

Immunocore, an Oxford-based biotechnology company developing novel biological drugs called ImmTACs to treat cancer and viral disease, has entered into a partnership with GlaxoSmithKline for multiple novel targets not addressable using antibody-based technologies. This is Immunocore's second major partnership this year.

More... »

Genomics England launched, DNA mapping

Wednesday, July 10, 2013 12:16 PM

Genomics England, an organization owned by DH, has launched a personal DNA code project. The personal DNA code—known as a genome—of up to 100,000 patients or infections in patients will be sequenced over the next five years.

More... »

Blackfield signs fourth pharmaceutical partnership

Wednesday, July 10, 2013 12:09 PM

Germany-based researcher Blackfield is collaborating with AstraZeneca. Blackfield will apply its genomics technologies and computational biology capabilities to validate preclinical models to support one of AZ’s oncology drug development programs.

More... »

E.U.-funded consortium to develop personalized brain cancer vaccines

Monday, July 8, 2013 12:09 PM

A project supported by a $7.7 million European Union Framework 7 (EU FP7) program grant to develop a novel class of therapeutic cancer vaccines is underway.

More... »

Novartis, Biological E partner to deliver affordable vaccines to developing world

Monday, July 8, 2013 12:07 PM

Novartis has entered into a development and licensing agreement with Biological E (BioE), a biopharmaceutical company based in India, for two vaccines to protect against typhoid and paratyphoid fevers. The agreement advances the Novartis goal to deliver accessible and affordable vaccines that address unmet medical need in endemic regions.

More... »